SAXONOV SERGE (Chief Executive Officer) sold 1.3% of their position (16.15K shares) of 10X GENOMICS, INC. on the open market
Open‑market sale worth $367.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/4/2026ACC: 0001610717-26-000086
DirectorOfficer10% Owner· Chief Executive Officer
Since Sep 2019
-18.90K
Net shares
Net seller
$367.1K
Total sold
2
Open market trades
0B · 2S
3
Total transactions
18.90K disposed
Non-Derivative Transactions3
Class A Common Stock
Direct
Shares
−14.29K
Price / share
$22.67
Trade value
$323.99K
% of position
1.2%
3/2/2026
1.22M→1.21M
Class A Common Stock
Direct
Shares
−1.86K
Price / share
$23.18
Trade value
$43.11K
% of position
0.2%
3/2/2026
1.21M→1.20M
Class A Common Stock
Direct
Shares
−2.75K
Price / share
—
Trade value
—
% of position
0.2%
3/3/2026
1.20M→1.20M
Total
Net shares
−18.90K
Net value
-$367.10K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 3/2/2026 | S · Sale | −14.29K | $22.67 | $323.99K | 1.2% | 1.22M | 1.21M |
| Class A Common Stock Direct | 3/2/2026 | S · Sale | −1.86K | $23.18 | $43.11K | 0.2% | 1.21M | 1.20M |
| Class A Common Stock Direct | 3/3/2026 | G · Gift | −2.75K | — | — | 0.2% | 1.20M | 1.20M |
| Total | −18.90K | -$367.10K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Class A Common Stock
IndirectShares owned58K
Class A Common Stock
IndirectShares owned27.00
Class A Common Stock
IndirectShares owned213.25K
Total
271.28K indirect271.28K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Common Stock | 58K | Indirect |
| Class A Common Stock | 27.00 | Indirect |
| Class A Common Stock | 213.25K | Indirect |
| Total | 271.28K | 271.28K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported